Company profile

Abbott

abbott.comHeadquarters: United States
10001+ employeesProduct Vendor
Abbott logo

Primary focus

Healthcare technologies in diagnostics, medical devices, nutrition, and pharmaceuticals.

Why it’s included

The profile lists multiple rapid immunodiagnostic tests such as the 'Panbio™ COVID-19 Ag Rapid Test Device' and 'BinaxNOW COVID-19 Ag Card', and explicitly states the company develops and manufactures point-of-care molecular and antigen diagnostics, directly matching the topic's requirements.

Relevant capabilities

  • Point-of-care and laboratory diagnostic test development (molecular, antigen, serology)
  • Biomarker assay development and clinical/analytical validation
  • Clinical laboratory automation and informatics integration
  • Regulatory submissions and interactions with major health authorities
  • Large-scale manufacturing and rapid production scale-up for diagnostics and devices
Commercial sectorInstrument-free rapid immunoassays
Technology classesConventional antibody-based lateral flow immunoassays

Relevant commercial products

  • Panbio™ COVID-19 Ag Rapid Test Device
  • Panbio COVID-19 Ag Rapid Test Device
  • BinaxNOW COVID-19 Ag Card
  • ID NOW™ COVID-19 24 Test Kit

Relevant patents

5 families, 5 publications
  • Magnetic immunosensor with trench configuration and method of use US-11402375-B2
  • Combined immunoassay and magnetic immunoassay systems and devices for extended range of sensitivity US-11680944-B2
  • Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity US-12025614-B2
  • Extended range immunoassay devices with immunosensor and magnetic immunosensor US-12601735-B2
  • Devices and methods for sample analysis US-11369963-B2

← Back to what’s inside this report